Doaa Mousa

Dr. Doaa Mousa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DMDoaa Mousa
Doaa Mousa
NZNourhan Zayed
Nourhan Zayed
IYInas A. Yassine
Inas A. Yassine
Alzheimer’s disease (AD) affects the quality of life as it causes; memory loss, difficulty in thinking, learning, and performing familiar tasks. Resting-state functional magnetic resonance imaging (rs-fMRI) has been widely used to investigate and analyze different brain regions for AD identification. This study investigates the effectiveness of using correlated transfer function (CorrTF) as a new biomarker to extract the essential features from rs-fMRI, along with support vector machine (SVM) ordered hierarchically, in order to distinguish between the different AD stages. Additionally, we explored the regions, showing significant changes based on the CorrTF extracted features’ strength among different AD stages. First, the process was initialized by applying the preprocessing on rs-fMRI data samples to reduce noise and retain the essential information. Then, the automated anatomical labeling (AAL) atlas was employed to divide the brain into 116 regions, where the intensity time series was calculated, and the CorrTF features were extracted for each region. The proposed framework employed the SVM classifier in two different methodologies, hierarchical and flat multi-classification schemes, to differentiate between the different AD stages for early detection purposes. The ADNI rs-fMRI dataset, employed in this study, consists of 167, 102, 129, and 114 normal, early, late mild cognitive impairment (MCI), and AD subjects, respectively. The proposed schemes achieved an average accuracy of 98.2% and 95.5% for hierarchical and flat multi-classification tasks, respectively, calculated using ten folds cross-validation. Therefore, CorrTF is considered a promising biomarker for AD early-stage identification. Moreover, the significant changes in the strengths of CorrTF connections among the different AD stages can help us identify and explore the affected brain regions and their latent associations during the progression of AD.

13 August 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
FFFayroz Farouk
Fayroz Farouk
NTNahed Tawfik
Nahed Tawfik
DMDoaa Mousa
Doaa Mousa
Mohamed S. AbdallahMohamed S. Abdallah
Mohamed S. Abdallah
YCYoung Im Cho
Young Im Cho
Genetic disorders affect over 6% of the global population and pose substantial obstacles to healthcare systems. Early identification of these rare facial genetic disorders is essential for managing related medical complexities and health issues. Many people consider the existing screening techniques inadequate, often leading to a diagnosis several years after birth. This study evaluated the efficacy of deep learning-based classifier models for accurately recognizing dysmorphic characteristics using facial photos. This study proposes a multi-class facial syndrome classification framework that encompasses a unique combination of diseases not previously examined together. The study focused on distinguishing between individuals with four specific genetic disorders (Down syndrome, Noonan syndrome, Turner syndrome, and Williams syndrome) and healthy controls. We investigated how well fine-tuning a few well-known convolutional neural network (CNN)-based pre-trained models—including VGG16, ResNet-50, ResNet152, and VGG-Face—worked for the multi-class facial syndrome classification task. We obtained the most encouraging results by adjusting the VGG-Face model. The proposed fine-tuned VGG-Face model not only demonstrated the best performance in this study, but it also performed better than other state-of-the-art pre-trained CNN models for the multi-class facial syndrome classification task. The fine-tuned model achieved both accuracy and an F1-Score of 90%, indicating significant progress in accurately detecting the specified genetic disorders.

6 December 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DMDoaa Mousa
Doaa Mousa
NZNourhan Zayed
Nourhan Zayed
IYInas A. Yassine
Inas A. Yassine
Neural plasticity is the ability of the brain to alter itself functionally and structurally as a result of its experience. However, longitudinal changes in functional connectivity of the brain are still unrevealed in Alzheimer’s disease (AD). This study aims to discover the significant connections (SCs) between brain regions for AD stages longitudinally using correlation transfer function (CorrTF) as a new biomarker for the disease progression. The dataset consists of: 29 normal controls (NC), and 23, 24, and 23 for early, late mild cognitive impairments (EMCI, LMCI), and ADs, respectively, along three distant visits. The brain was divided into 116 regions using the automated anatomical labeling atlas, where the intensity time series is calculated, and the CorrTF connections are extracted for each region. Finally, the standard t-test and ANOVA test were employed to investigate the SCs for each subject’s visit. No SCs, along three visits, were found For NC subjects. The most SCs were mainly directed from cerebellum in case of EMCI and LMCI. Furthermore, the hippocampus connectivity increased in LMCI compared to EMCI whereas missed in AD. Additionally, the patterns of longitudinal changes among the different AD stages compared to Pearson Correlation were similar, for SMC, VC, DMN, and Cereb networks, while differed for EAN and SN networks. Our findings define how brain changes over time, which could help detect functional changes linked to each AD stage and better understand the disease behavior.

20 December 2023 in Alfarama Journal of Basic & Applied Sciences
Verified
Journal Article
Open access
DMDoaa Mousa
Doaa Mousa
Mahmoud Y. ShamsMahmoud Y. Shams
Mahmoud Y. Shams
A. A. SalamaA. A. Salama
A. A. Salama
The field of medical image mining has garnered significant attention from researchers and professionals alike. This paper delves into the challenges and issues associated with medical images, such as low accuracy, poor quality, and false features. In response, we propose a prototype framework that utilizes image processing and data mining to enhance diagnostic decision-making through the extraction of relevant features from medical images. Firstly, the framework implements image processing algorithms to address problems related to brightness and imaging environment, thereby improving the quality of targeted medical images. Secondly, image mining techniques, such as segmentation and clustering, are employed on the processed images to identify and extract pertinent indicators. The model is trained iteratively using reference images, and classification techniques are utilized to identify features in test medical images. The prototype, developed using MATLAB, was tested on medical images of patients suspected to have leukemia. Results demonstrate that the proposed framework outperforms many comparable models using the same dataset, with a maximum accuracy of 98% achieved using K-mean segmentation and Super vector machine (SVM) clustering, compared to the 85-95% accuracy of commonly used frameworks for leukemia diagnosis. Validation of the proposed model confirms its adequacy and highlights the value added by incorporating image mining after preprocessing medical images using typical image enhancement techniques.